文献速递眼底病与葡萄膜炎

血管黏附蛋白-1阻断抑制小鼠视网膜激光光凝后的眼部炎症

Vascular Adhesion Protein-1 Blockade Suppresses Ocular Inflammation After Retinal Laser Photocoagulation in Mice.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究用VAP-1抑制剂RTU-1096喂养C57BL/6JJcl小鼠7天后行周边视网膜激光光凝,检测血浆与脉络膜视网膜SSAO活性、OCT视网膜各层厚度、玻璃体内白细胞浸润及视网膜ICAM-1表达;结果显示RTU-1096可抑制激光所致外核层增厚、炎症细胞浸润与玻璃体视网膜表面高反射灶,并减少ICAM-1上调。

要点

  • 激光光凝后1天激光组外核层增厚,RTU-1096给药可消除该增厚
  • 激光所致炎症细胞浸润和玻璃体视网膜表面高反射灶均被RTU-1096抑制
  • 全身给予RTU-1096减少视网膜白细胞黏附分子ICAM-1的上调

核心结论

  • 作者认为VAP-1/SSAO抑制可能成为预防缺血性视网膜疾病(如糖尿病视网膜病变)患者接受散射激光光凝后继发黄斑水肿的潜在治疗策略。

研究设计与样本

  • C57BL/6JJcl小鼠自由进食含VAP-1特异性抑制剂RTU-1096的饲料或对照饲料7天,随后对周边视网膜行激光光凝。
  • 检测血浆与脉络膜视网膜组织的SSAO活性,于激光前及激光后1、3、7天行OCT并测量各视网膜层厚度,组织学分析评估玻璃体内白细胞浸润,实时定量PCR检测视网膜ICAM-1表达。

主要发现

  • 激光光凝后1天,激光组外核层厚度较对照组增加,RTU-1096给药消除了外核层增厚。
  • 组织学分析与OCT观察显示激光光凝引起炎症细胞浸润及玻璃体视网膜表面高反射灶,两者均被RTU-1096给药抑制。
  • 全身给予RTU-1096减少了视网膜白细胞黏附分子ICAM-1的上调。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the effect of the vascular adhesion protein-1 (VAP-1) inhibitor RTU-1096 on retinal morphologic changes and ocular inflammation after retinal laser photocoagulation in mice. METHODS: C57BL/6JJcl mice were fed a diet containing RTU-1096, a specific inhibitor for VAP-1, or a control diet ad libitum for 7 days. Laser photocoagulation was performed on the peripheral retina of the animals. The semicarbazide sensitive amine oxidase (SSAO) activities in plasma and chorioretinal tissues were measured. Optical coherence tomography (OCT) images were acquired before and at 1, 3, and 7 days after laser photocoagulation, and thickness of the individual retinal layers was measured. Intravitreal leukocyte infiltration was assessed by histologic analysis. The expression level of intercellular adhesion molecule-1 (ICAM-1) in retinal tissues were examined by quantitative real-time PCR. RESULTS: One day after laser photocoagulation, the thickness of the outer nuclear layer (ONL) increased in the laser group compared with in the control group, and RTU-1096 administration abrogated the ONL thickening. Histologic analysis and OCT observation revealed that laser photocoagulation caused infiltration of inflammatory cells and the appearance of hyperreflective foci at the vitreoretinal surface, both of which were suppressed by RTU-1096 administration. In addition, systemic administration of RTU-1096 reduced upregulation of the leukocyte adhesion molecules ICAM-1 in the retina. CONCLUSIONS: The current data indicate that VAP-1/SSAO inhibition may be a potential therapeutic strategy for the prevention of macular edema secondary to scatter laser photocoagulation in patients with ischemic retinal diseases such as diabetic retinopathy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Matsuda T, Noda K, Murata M, et al. Vascular Adhesion Protein-1 Blockade Suppresses Ocular Inflammation After Retinal Laser Photocoagulation in Mice. Invest Ophthalmol Vis Sci. 2017. PMID: 28662230. doi:10.1167/iovs.17-21555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。